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Saccharomyces cerevisiae Is Dependent on Vesicular Traffic
between the Golgi Apparatus and the Vacuole When
Inositolphosphorylceramide Synthase Aur1 Is Inactivated
Natalia S. Voynova,a* Carole Roubaty,a Hector M. Vazquez,a Shamroop K. Mallela,a Christer S. Ejsing,b Andreas Conzelmanna
Division of Biochemistry, Department of Biology, University of Fribourg, Fribourg, Switzerlanda; Department of Biochemistry and Molecular Biology, VILLUM Center for
Bioanalytical Sciences, University of Southern Denmark, Odense M, Denmarkb
Inositolphosphorylceramide (IPC) and its mannosylated derivatives are the only complex sphingolipids of yeast. Their synthesis
can be reduced by aureobasidin A (AbA), which specifically inhibits the IPC synthase Aur1. AbA reportedly, by diminishing IPC
levels, causes endoplasmic reticulum (ER) stress, an increase in cytosolic calcium, reactive oxygen production, andmitochon-
drial damage leading to apoptosis. We found that when Aur1 is gradually depleted by transcriptional downregulation, the accu-
mulation of ceramides becomes a major hindrance to cell survival. Overexpression of the alkaline ceramidase YPC1 rescues cells
under this condition. We established hydroxylated C26 fatty acids as a reliable hallmark of ceramide hydrolysis. Such hydrolysis
occurs only when YPC1 is overexpressed. In contrast, overexpression of YPC1 has no beneficial effect when Aur1 is acutely re-
pressed by AbA. A high-throughput genetic screen revealed that vesicle-mediated transport between Golgi apparatus, endo-
somes, and vacuole becomes crucial for survival when Aur1 is repressed, irrespective of the mode of repression. In addition, vac-
uolar acidification becomes essential when cells are acutely stressed by AbA, and quinacrine uptake into vacuoles shows that
AbA activates vacuolar acidification. The antioxidantN-acetylcysteine does not improve cell growth on AbA, indicating that re-
active oxygen radicals induced by AbA play a minor role in its toxicity. AbA strongly induces the cell wall integrity pathway, but
osmotic support does not improve the viability of wild-type cells on AbA. Altogether, the data support and refine current models
of AbA-mediated cell death and add vacuolar protein transport and acidification as novel critical elements of stress resistance.
Yeast sphingolipids have been recognized to be essential for cellgrowth and survival ever since the initial demonstration by
Bob Dickson and colleagues that LCB1 and LCB2, coding for two
components of serine palmitoyltransferase, are essential genes (1)
(Fig. 1). In 1997 the same group also demonstrated that the essen-
tial AUR1 gene encodes the enzyme making inositolphosphoryl-
ceramides (IPCs), implying that IPCs are essential for cell growth
(2); in contrast, the synthesis of mannosyl-IPCs (MIPCs) and ino-
sitol-phospho-MIPCs [M(IP)2Cs] was found to be dispensable
(3–5). The essentiality of IPCs, however, has been questioned,
since cells lacking all ceramide synthases are highly resistant to the
inhibitor aureobasidin A (AbA), a very specific and potent inhib-
itor of Aur1, which rapidly induces cell death in wild-type (WT)
yeast cells (6–9). Nevertheless, several lines of evidence suggest
that IPCs are essential for growth. This had been already suggested
by early studies showing that the lethality of the lcb1 mutation
(Fig. 1), eliminating all sphingolipid biosynthesis, is suppressed in
cells harboring the SLC1-1 gain-of-function mutation, which al-
lows making phosphatidylinositol (PI) with the very-long-chain
fatty acid (VLCFA) C26:0 in the sn-2 position. Structurally, this
abnormal PI closely resembles IPC and allows growth of sphingo-
lipid-free and ceramide-free yeast strains (10–13). Furthermore, a
recent report showed that AbA causes the endoplasmic reticulum
(ER) retention of glycosylphosphatidylinositol (GPI)-anchored
proteins, an unfolded protein response, reactive oxygen species
(ROS) production, mitochondrial cytochrome c release, and a
metacaspase-mediated form of apoptosis that additionally is de-
pendent on the concomitant increase of cytosolic Ca2 concen-
trations, all through the reduction of IPCs rather than the accu-
mulation of toxic ceramides, both of which are inevitable
consequences of Aur1 depletion/inhibition (14).
AbA has fungicidal activity against many pathogenic fungi, in-
cluding Candida albicans, Cryptococcus neoformans, and some
Aspergillus species. Given orally to mice, AbA was effective at cur-
ing candidiasis and well tolerated (15). Moreover, AbA-mediated
cell death represents a tractable model of sphingolipid-mediated
apoptosis.
Here, in an attempt to further understand the mechanisms of
AbA-induced apoptosis and to discriminate between effects
linked to IPC depletion versus ceramide accumulation, we did
chemical/genetic high-throughput screens testing the growth of
deletion mutants under Aur1 repression, either when overex-
pressingYPC1 or when not.YPC1 is an ER ceramidase that has the
potential to lower ceramide levels and concomitantly aggravate
the reduction of complex sphingolipids. Overexpression of YPC1
has been reported to have various biological effects, e.g., in making
cells resistant to exogenous long-chain bases (LCBs) (16) by work-
ing in the reverse direction (converting LCBs to ceramides) or to
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make cells hypersensitive to hydroxyurea (17) and to rescue high-
temperature growth of ypk1ts ypk2 cells (18) by working as a
ceramidase.
MATERIALS AND METHODS
Strains, growth conditions, and materials. The Saccharomyces cerevisiae
strains used are listed in Table S1 in the supplemental material, plasmids
in Table S2 in the supplemental material, and the origin of chemicals in
the materials section in the supplemental material. Mutant strains and
plasmids were generated using standard methods for crossing of single
mutants, plasmid transfection, or gene disruption using deletion cassettes
generated by PCR. Unless indicated otherwise, cells were grown on rich
medium (yeast extract-peptone-dextrose [YPD] or YPGal) supplemented
with uracil and adenine or on synthetic complete (SC) medium (yeast
nitrogen base [YNB]) (United States Biological) containing 2% glucose
(D) or galactose (Gal) as a carbon source plus the amino acids and ingre-
dients contained in the dropout mix. For serial dilution growth assays,
agar plates were incubated for 3 days at 30°C unless indicated otherwise.
Construction of plasmids. To construct plasmid pYPC1-URA3, the
coding sequence of YPC1 was amplified by PCR using oligonucleotides
5=-CCTGGGATCCATGGGAATATTTCGTTGGAAC-TATCC-3= and
5=-CGCCGCGGCCGCTTACTTCTCCTTTTTAACTTC-3= from genomic
DNA of BY4742 cells. The PCR products were doubly digested with NotI
and BamHI and ligated into the similarly digested centromeric pNP302
vector carrying the ADH1 promoter to generate pYPC1-URA3. To make
the tetAUR1 strain FBY5318,AUR1was placed under control of the tetO2
promoter by replacing 110 bp preceding the ATG initiator codon by the
tetracycline operator cassette containing a repressor-binding site, a tetR-
VP16 tTA transactivator, and the kanMX4 marker, amplified from plas-
mid pCM224 (19). Subsequently, the kanMX4 cassette was replaced by
the natMX cassette using a fragment from the marker swap plasmid
pAG25 (20).
SGA. Synthetic genetic array (SGA) analysis was performed as follows.
Briefly, the FBY5313 WT, tetAUR1, tetAUR1.YPC1, or tetAUR1.URA3
strain was robotically crossed against an array of 5,044 individual knock-
outs of nonessential genes, with each cross being done in quadruplicate.
After sporulation, colonies were pinned onto medium without histidine,
arginine, lysine, and uracil and supplemented with canavanine and thia-
lysine and were left for 2 days at 30°C to select for MATa haploid meiotic
progeny (selection 1). When crossing tetAUR1 strains, plates were then
replicated on the same medium additionally containing Geneticin (G418)
and nourseothricin (clonNAT) (selection 2). After 1 day at 30°C, colonies
were replicated onto the same medium (selection 3), the same medium
plus 0.03 g/ml of AbA, or the same medium plus 0.1 g/ml of doxycy-
cline (Doxy). Pictures were taken after 36 h of growth. The measurement
of growth and the analysis and visualization of the data were conducted
with the help of the “ScreenMill” software (21), giving positive Z scores for
growth defects and negative ones for growth enhancement. Plating of
serially 10-fold-diluted cells on nutrient agar was used in the preliminary
screens to see whether the synthetic genetic interactions identified by SGA
analysis could be reproduced in a simple growth assay.
Fluorescencemicroscopy.Cells were imaged using an Olympus BX54
microscope equipped with a piezo-positioner (Olympus). Z sections (0.5
m thick, 7 to 10/cell) were projected to two-dimensional images and
analyzed with the CellM software (Olympus).
Analysis of lipids by MS. Lipids were extracted and analyzed in neg-
ative- and positive-ion modes by direct infusion mass spectrometry (MS)
using an LTQ Orbitrap XL mass spectrometer equipped with the auto-
mated nanoflow ion source Triversa NanoMate (Advion Biosciences) as
described previously (22, 23). Data were expressed either as intensity pro-
filing (lipid analyte intensity normalized to the sum of intensities of all
monitored lipid analytes) or as mole percent (based on internal lipid
standards) (22, 23).
Detection of IPC/MIPC by metabolic labeling with [3H]inositol.
Cells were grown at 30°C overnight in inositol-free SC medium buffered
to pH 5 with 50 mM sodium phosphate and 50 mM sodium succinate and
were resuspended in the same medium at an optical density at 600 nm
(OD600) of 10 for labeling. To aliquots of 2.5 OD600 units of cells we added
AbA (from a 200-fold-concentrated stock in ethanol); after 10 min,
[3H]inositol (10 Ci) was added. Every 40 min the labeling media were
replenished by adding 1 volume of 5-fold-concentrated SC medium
(buffered as described above) to 4 volumes of culture. Labeling was ter-
minated after 2 h, and lipids were extracted as recently described (24) and
desalted using butanol-water partitioning or Folch partitioning; the latter
does not completely retain M(IP)2C in the organic phase. Lipids were
deacylated using NaOH as described previously (25). The final lipid ex-
tracts contained 20 to 40% of added radioactivity, depending on the ex-
periment. Lipids were separated by thin-layer chromatography (TLC) us-
ing CHCl3–methanol– 0.25% KCl (55:45:10) as a solvent and were
quantified by two-dimensional Berthold radioscanning. After mild base
treatment, only the various forms of IPC, MIPC, and M(IP)2C were left.
Detection of ceramides and IPC/MIPC by metabolic labeling with
[14C]serine. Aliquots of 5 OD600 units of cells were preincubated for 10
min with AbA as required and labeled in 1 ml of serine-free SC medium
with 10 Ci of [14C]serine for 5 h at 30°C with shaking and addition of
5-fold-concentrated serine-free SC medium every 40 min. At the end, the
optical density of cultures was determined, and trichloroacetic acid (TCA)
was added to a final concentration of 5% (wt/vol). Cells were washed in
water, and lipids were extracted, deacylated or not by NaOH, desalted by
Folch partitioning, and analyzed by TLC in the solvent chloroform–meth-
anol– 4.2 N ammonia (9:7:2) followed by radioscanning.
Quinacrine staining. Quinacrine staining was performed as detailed
in the supplemental material.
FIG 1 Major pathways of sphingolipid biosynthesis in yeast. Gene names are
in italic, essential genes are in green, activities dependent on protein complexes
are in gray, and enzyme inhibitors are in bold italic. A detailed description of
the biosynthetic reactions can be found in recent reviews (58, 67). Deletions of
red and blue genes are predicted or known to reduce ceramide levels; those that
scored as suppressors of the growth defect of strains with repressed AUR1
transcription are in red, and those which did not score, although present in the
deletion library, are in blue. Deletions in the 5 underlined genes also were
identified as suppressors in preliminary screens and were confirmed in serial
dilution plating assays (Table 2). Long-chain bases (LCBs) of ceramides are
dihydrosphingosine (DHS) or phytosphingosine (PHS); fatty acids of cer-
amides are indicated by the number of C atoms (e.g., C26) and their hydroxyl
(OH) groups.
Voynova et al.
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RESULTS
Overexpression ofYPC1 induces futile ceramide hydrolysis and
reduces levels of newly synthesized ceramides. As the double
deletion ypc1 ydc1 strain has normal ceramide levels even in
the presence of AbA (24), we investigated whether there was in-
creased ceramide turnover in cells overexpressing YPC1. In view
of later experiments, we tested this also in strains in which the
natural promoter of AUR1 was replaced by the doxycycline-re-
pressible tetoff promoter (tetAUR1 strains) and which constitu-
tively overexpress eitherYPC1 (tetAUR1.YPC1) or cytosolic green
fluorescent protein (GFP) as a negative control (tetAUR1.URA3).
As shown in Fig. 2A, YPC1-overexpressing cells had significantly
higher levels of free LCBs than several WT, scs7, or ypc1 ydc1
(yy) cells, and LCB levels could further be increased by AbA
treatment, although such treatment did not increase LCB levels in
normal cells. As seen in Fig. 2B, free VLCFAs were very low in cells
not overexpressing YPC1, and AbA treatment of such cells led to
the appearance mainly of nonhydroxylated C26:0;0. YPC1-overex-
pressing cells generally had higher levels of VLCFAs and, remark-
ably, had significant amounts of monohydroxylated VLCFAs
(C24:0;1 and C26:0;1). The small amounts of C26:0;1 seen in AbA-
treated WT cells (asterisk in Fig. 2B) were not detectable in AbA-
treated scs7 cells lacking the -hydroxylase for fatty acids (not
shown). Lipid profiles generated by MS showed that hydroxylated
VLCFAs were not detectable in triacylglycerols (TAGs) or glycero-
phospholipids of tetAUR1.YPC1 (not shown), suggesting that
C26:0-OH-coenzyme A (CoA) either is not made or is not utilized
for glycerolipid biosynthesis. Ceramides and IPCs with hydroxy-
lated VLCFAs were reported to be reduced in sur2 cells not mak-
ing phytosphingosine (PHS) (Fig. 1), and this led to the proposal
that the VLCFA hydroxylase Scs7 utilizes as substrates only fatty
acids that are part of ceramides or IPCs but neither acyl-CoA nor
free fatty acids (26). The fact that free hydroxylated VLCFAs be-
come detectable only upon overexpression of YPC1 strongly sup-
ports this view. This fact also suggests that in at least some com-
partment of WT cells, probably the ER, the concentrations of
ceramide, LCBs, and fatty acids favor ceramide hydrolysis, i.e.,
that the G= for ceramide hydrolysis is negative but that hydroly-
sis does not occur because ceramidases are rate limiting for this
process unless they are overexpressed.
AbA treatment caused a normal increase in concentrations of
nonhydroxylated VLCFAs (C26:0;0) in various ypc1 ydc1 cells
(see Fig. S1 in the supplemental material). These free VLCFAs
therefore are not generated by ceramide hydrolysis, suggesting
that AbA increases local ceramide levels to the point that the acyl-
CoA-dependent ceramide synthase slows down so that C26:0;0-
CoA accumulates and either can be hydrolyzed directly or is used
for the synthesis of TAGs from where C26:0;0 can be released by
TAG-lipases (27). Metabolic labeling with [14C]serine demon-
strated that overexpression of YPC1 indeed can decrease the levels
of newly made ceramides, and this was observed even in WT cells
in the absence of AbA treatment (see Fig. S2B), although in such
cells little C26:0;1 is detectable by MS (Fig. 2B). Different types of
ceramides were affected differently by YPC1 overexpression, with
dihydrosphingosine-C26 (DHS-C26) apparently not being affected
(see Fig. S2B).
Effects of YPC1 overexpression in cells having a reduced
Aur1 activity. The data above suggested that YPC1, by hydrolyz-
ing ceramides, would potentially alter the ceramide levels or cer-
amide-to-IPC ratio at least at certain subcellular locations, and we
therefore compared the growth of serially diluted tetAUR1.YPC1
and tetAUR1.URA3 cells on agar in the presence of AbA or doxy-
cycline (Doxy). As seen in Fig. 3A and B, concentrations of 0.01
g/ml of AbA or 0.3g/ml of Doxy moderately reduced growth of
cells on glucose by factors of 10 to 100, i.e., 10- to 100-fold more
cells had to be plated on AbA or Doxy to see growth similar to that
seen in the absence of drugs. As seen in Fig. 3A, overexpression of
YPC1 from the ADH1 or GAL1 promoter enhanced the toxicity of
AbA; this effect was observed in most but not all of experiments. In
contrast, when AUR1 was downregulated transcriptionally using
Doxy, we consistently observed that the overexpression of YPC1
rescued the growth defect (Fig. 3B). This was the case both when
YPC1 was overexpressed constitutively and when it was induced
by galactose. It seems safe to assume that downregulation of IPC
synthase activity in the presence of Doxy sets in more slowly than
when cells are simply plated on AbA, and we therefore hypothe-
sized that this kinetic difference may cause different stress situa-
tions, which are differently affected by YPC1 overexpression. In-
deed, treatment of cells with 10 g/ml of Doxy required 8 h to
reduce incorporation of [3H]inositol into IPCs by 90% (not
shown), whereas many previous experiments in our lab show that
FIG 2 Overexpression of YPC1 induces ceramide hydrolysis. The indicated
strains were grown to an OD600 of 0.7 and extracted either directly or only after
further growth in the presence of AbA (0.25 g/ml) during 4 h. Lipid extracts
from equal cell numbers were analyzed by MS. LCBs and VLCFAs are specified
by 3 numbers indicating carbon atoms:double bonds;OH groups. (A) All in-
tensities of LCB18:0;3 and LCB20:0;3 detected in the 6 strains, after subtraction of
background, were summed and set as 100% and each species in each strain
expressed as a fraction thereof. Summed intensities in LCB20:0;3 were only 6%
of the total and therefore were multiplied by 10 for better visibility. Results for
strains with an asterisk represent averages from two independent experiments
and those for others represent a single one; two technical repeats were done in
all cases. (B) Plot of the relative abundances (mole percent) of free VLCFA
species that were present. Results represent averages from two independent
experiments and two technical repeats for each.
Genetic Interactions of Yeast Aur1
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the effect of AbA on Aur1 is rather instantaneous (28). Also, treat-
ment for 3 h with AbA (0.25 g/ml) induced strong phosphory-
lation of the terminal mitogen-activated protein kinase (MAPK)
Slt2 of the wall integrity (CWI) pathway and TORC2-dependent
phosphorylation of Ypk1 at Thr662 (29, 30), whereas Doxy treat-
ment (10g/ml) for 3 h did not increase or only slightly increased
phosphorylation of these kinases (Fig. 3C; see Fig. S3 in the sup-
plemental material). Phosphorylation of Slt2 under AbA was re-
duced when YPC1 was overexpressed (Fig. 3C; see Fig. S3). The
chitin-binding Calcofluor white (CFW) can induce strong phos-
phorylation of Slt2 (31) but failed to do so in our strain back-
ground (Fig. 3C; see Fig. S3).
Overexpression of membrane proteins is known to induce an
unfolded-protein response (UPR), and the UPR has been shown
to increase the synthesis of sphingolipids in yeast (32). To see if
overexpression of YPC1 causes the observed effects by inducing or
enhancing a UPR, we also overexpressed enzymatically “dead”
versions of YPC1 that do not display any Ypc1 activity in vivo or in
vitro. As shown in Fig. 4A, overexpression of catalytically dead
versions of YPC1 had no effect on the sensitivity of cells to AbA or
Doxy, although they were expressed almost as strongly as WT
Ypc1 (Fig. 4B).
In view of the different kinetics of AbA- and Doxy-mediated
repression of Aur1, we tested if prolonged treatment with Doxy is
able to kill cells, as is well described for AbA. Indeed, Doxy treat-
ment for 7 h killed a substantial fraction of WT as well as hyper-
sensitive mutant cells (see Fig. S4 in the supplemental material).
Overexpression of YPC1modulates AbA and Doxy sensitiv-
ity of the tetAUR1 strain by decreasing IPC and ceramide levels,
respectively. We surmised that overexpression of YPC1 rescues
the Doxy-induced growth defect either by reducing toxic cer-
amide levels or by increasing LCB levels but not by further de-
creasing IPCs. To investigate this positive effect further, we de-
cided to explore alternative ways to reduce ceramides. For this we
utilized australifungin, a specific inhibitor of ceramide synthase
(33) (Fig. 1). Australifungin, similar to YPC1 overexpression, re-
duces IPCs and ceramides and increases LCBs. In parallel, we also
used myriocin, a specific inhibitor of Lcb1/Lcb2 (34) (Fig. 1),
which reduces both ceramides and LCBs. As shown in Fig. 4C, the
compromised growth of tetAUR1 cells on Doxy was improved
when australifungin or myriocin was present at concentrations
which did not have any effect on cell growth on their own. Thus,
the data suggest that the growth-promoting effect of YPC1 over-
expression on Doxy-treated tetAUR1 cells comes about through
reduction of toxic ceramides, not elevation of LCBs.
As to AbA-treated cells, we surmised that the usually observed
YPC1-mediated growth reduction could be caused either by re-
duction of complex sphingolipids or by a rise of LCBs to toxic
levels, whereas it seemed a priori excluded that YPC1 would com-
promise growth on AbA by reducing the elevated ceramide levels.
As australifungin and myriocin increased the toxicity of AbA (Fig.
4C), we conclude that AbA is toxic through reduction of complex
sphingolipids. This interpretation is in agreement with a recent
study of the effect of the conditional lcb1-100 mutation on AbA
sensitivity which concluded that the reduction of complex sphin-
golipid levels but not the increase of ceramide levels is critical for
AbA-induced cell death (14).
Thus, we propose that the immediate stress for cells upon acute
Aur1 inhibition on AbA may be the lack of IPCs, whereas the
growth-limiting factor during a more protracted Aur1 repression
under Doxy may be the toxicity of ceramides.
The above-mentioned study and a second one recently re-
ported that AbA (0.05g/ml for 4 h or 0.5g/ml for 1 h) as well as
myriocin induces strong increases of ROS in WT cells (14, 35) and
that the membrane-permeating antioxidant N-acetylcysteine
(NAC) could rescue growth of cells on 0.4 g/ml of myriocin. In
our hands, NAC did not improve the growth of tetAUR1 cells on
AbA (Fig. 4D) or on Doxy (not shown), although it efficiently
antagonized the toxic effect of the ROS-generating oxidant para-
quat (Fig. 4E). NAC also did not decrease toxicity of AbA in vac-
uolar acidification (vma) mutants, which are known to be hyper-
sensitive to reactive oxygen radicals (36) and were found to be
AbA hypersensitive (see below) (Fig. 4D). Thus, the ROS gener-
ated by AbA treatment may not be relevant for its proapoptotic
action.
Genetic interaction profile of cells with depressed AUR1 ac-
tivity as revealed by SGA analysis. Previous low-throughput
studies found sac1, scs7, lcb1-100, stt4ts, aur1ts, gpi1, gpi2-7,
FIG 3 Overexpression of YPC1 influences the growth of tetAUR1 cells de-
pending on the mode of AUR1 repression. (A and B) Tenfold dilutions of cells
carrying vectors for overexpression of YPC1 or the control vector were spotted
on glucose- or galactose-containing medium. Two centromeric vectors having
YPC1 either behind the strong constitutive promoter of ADH1 or behind the
galactose-inducibleGAL1 promoter were utilized. Growth media were supple-
mented with AbA or Doxy as indicated. In this experiment, cells plated on
glucose or galactose had been precultured on that same carbon source before
plating, but the same result was also obtained when all cells had been precul-
tured on glucose (not shown). (C) The indicated strains were grown in SC
medium to exponential phase (OD600 0.5 to 0.7) and further treated for 3 h
with either Calcofluor white (CFW) (5.0 g/ml), AbA (3.0 g/ml), or Doxy
(10.0 g/ml). Proteins were extracted and resolved by SDS-PAGE. Phosphor-
ylated Slt2 (pSlt2) and Ypk1 (pYpk1, phosphorylated on Thr662) were de-
tected as described previously (30). Sec63 was used as a loading control. For the
quantifications of pSlt2 shown on the tops of lanes, data were normalized with
regard to the amount of Sec63 and expressed as a fraction of results for non-
treated cells (1.00).
Voynova et al.
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gpi3-10, arv1, gaa1-1, lem3, and sch9 cells to be hypersensitive
to AbA or genetic repression of AUR1 but lac1 lag1, lip1, elo3
(sur4), sur2, yca1, and pdr5 yor1 cells to be hyperresistant
(14, 29, 37–43). To get a more comprehensive picture, we per-
formed a genetic screen in which a large collection of mutants,
each having a nonessential gene replaced by the kanMX resistance
marker, were crossed with tetAUR1.YPC1 and tetAUR1.URA3
query strains. After sporulation, haploids that were uracil pro-
totrophs and bore the Doxy-repressible AUR1 and a kanMX4 al-
lele were selected and placed in the last selection round on either
0.03 g/ml AbA, 0.1 g/ml Doxy, or control medium, so that we
finally observed growth of each nonlethal deletion under 6 differ-
ent conditions (Fig. 5A).
Five binary comparisons were made, as shown by arrows in Fig.
5A. The growth defect of a given mutant under drug treatment
compared to its growth without drug was compared with the av-
erage difference of all mutants in a given binary comparison, and
only differences with P values of 0.05 (|Z score|  1.95) were
considered to be significant. (The full set of interactions is given in
Table S3A in the supplemental material, and deletions giving very
strong interactions in most comparisons shown in Fig. 5A are
listed in Table S3B in the supplemental material.) Strains highly
sensitive to Aur1 repression (positive Z score) in binary compar-
isons 1 to 4 overlapped only partially (Fig. 5B). This most likely is
due not only to the different modes of Aur1 repression and differ-
ent Ypc1 levels but also to the significant number of false-positive
hits generated by the SGA (44, 45). However, if any biological
process becomes essential under a particular stress condition
tested, one expects an increased frequency of hits among genes
involved in that process, i.e., annotated by the corresponding gene
ontology (GO) terms describing “biological process” in the Sac-
charomyces Genome Database (SGD) (http://www.yeastgenome
.org/). We find that that negative interactors in each one of the 4
screens shown in Fig. 5B were strongly enriched for genes attrib-
uted to GO terms concerning vesicle-mediated transport between
the Golgi apparatus, endosomes, and vacuole (Table 1; see Table
S4 in the supplemental material). Depending on the localization
or their products, genes are also annotated by GO terms describ-
ing the “cellular component,” and the GO term enrichments in
negative interactors (GENIs) concerning the “cellular compo-
nent” in our screens similarly are concentrated on the Golgi ap-
paratus and endosomes (Table 1; see Table S4 in the supplemental
material). Among the 371 deletions giving significant negative in-
teractions in comparisons 1 to 4 (Fig. 5A), 42 belong to the GO
term “vacuolar transport.” Of those, 22 had previously been found
to be vacuolar protein sorting (vps) mutants (see Fig. S5A in the
supplemental material). vps mutants also stood out qualitatively,
as they were overrepresented among the deletions giving the
strongest negative interactions on AbA and Doxy (see Table S3B
in the supplemental material). The GO terms of Table 1 were of
course also strongly enriched in mutants found in more than one
screen (fields a to k in Fig. 5B) (see Tables S3B and S5 in the
supplemental material), but they were completely absent in mu-
tants found in only a single screen (fields l, m, n, and o in Fig. 5B).
Indeed, practically no GO terms were enriched in negative inter-
actors found only in a single screen (see Table S5 in the supple-
mental material), indicating that many of them may be false-pos-
itive hits. In the following, negative interactions found in two or
more screens, i.e., comprised in fields a to k of Fig. 5B, are there-
fore referred to as the “high-confidence set.”
FIG 4 Effects of dead YPC1 alleles, australifungin, and myriocin on cells hav-
ing reduced IPC synthase activity. (A) Serial dilutions of cells overexpressing
either WT or two functionally dead forms of YPC1 (denoted * and **) were
plated on plates containing AbA or Doxy. (B) tetAUR1 containing hemagglu-
tinin (HA)-tagged YPC1, empty vector, or the two dead alleles of YPC1 behind
theGAL1 promoter were grown in galactose for 20 h, and extracts correspond-
ing to 1 OD600 unit of cells were Western blotted using anti-HA. (C) Upper two
rows, serial dilutions of tetAUR1 were spotted on YPD and YPD supplemented
with 0.25 g/ml Doxy, 0.03 g/ml AbA, 1.50 g/ml australifungin, or combi-
nations thereof at the same concentrations. Lower two rows, cells were also
spotted on media supplemented with 0.50 g/ml Doxy, 0.01 g/ml AbA, or
0.05 g/ml myriocin or combinations thereof at same concentrations. Plates
were incubated for 2 days at 30°C. (D) Tenfold dilutions of vmamutants in the
BY4742 (WT) or tetAUR1 background were spotted onto YPD plates with the
indicated concentrations of AbA and NAC. (E) To demonstrate the efficacy of
NAC in antagonizing the deleterious effects of ROS, the ROS-hypersensitive
sod1 cells, lacking cytosolic superoxide dismutase, were included to show
that the growth inhibition caused by paraquat, an oxidant, can be antagonized
by NAC.
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Figure 5C and D show that the Z scores on AbA versus Doxy
were positively correlated but not very strongly. This again
suggests that the stresses on AbA versus Doxy are not quite the
same and that cells depend on different genes to overcome them.
Figure 5B also clearly shows that the genes identified in the
tetAUR1.URA3 background only partially overlap those found in
the tetAUR1.YPC1 background, but scores obtained with the two
strain backgrounds showed considerable positive correlation (Fig.
5E and F).
Mere overexpression of YPC1 in the absence of drugs (arrow 5
FIG 5 Screens identifying gene deletions making cells sensitive or resistant to Aur1 repression. (A) Each of the 4,849 deletion strains was crossed with either
tetAUR1.URA3 or tetAUR1.YPC1, and haploid progeny harboring a gene deletion, the tetAUR1 allele, and an URA3 plasmid were selected on plates supple-
mented with no drug, AbA, or Doxy. The relative growth of each mutant was determined by 5 binary comparisons between conditions linked by a double-
pointing arrow. (B) Venn diagram classifying deletion mutants growing worse than average underAUR1 repression (positive Z scores) according to the screen(s)
(comparisons 1 to 4 in panel A) that identified them. Different fields denoted by letters are referred to in the text and in Table S5 in the supplemental material and
are followed by the number of negative interactors identified in this category. (C) For each deletion in the tetAUR1.URA3 background giving a significant
interaction on at least one of the drugs (P 0.05, |Z score| 1.95), the Z scores on Doxy were plotted against the Z scores on AbA. (D) Same as for panel C but
for deletions in the tetAUR1.YPC1 background. (E) Z scores in comparison 1 (panel A) plotted against their Z scores in comparison 3 for 174 mutants giving
significant scores in either one of these screens. Twenty-nine strains giving a significant score in comparison 5 of panel A were excluded. (F) Same as for panel E
but plotting scores in comparison 2 versus comparison 4 for 343 mutants after removal of 43 strains giving a significant score in comparison 5. (G) Venn diagram
indicating overlaps between gene deletions causing significant growth retardation of hypomorphic aur1 alleles according to BIOGRID and the “high-confidence
set” (panel B, fields a to k). (H) Z scores of tetAUR1.URA3 versus those of tetAUR1.YPC1 on AbA (top) and on Doxy (bottom) for deletions in mitochondrial
genes.
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in Fig. 5A) resulted in 81 and 88 significant interactions with pos-
itive and negative Z scores, respectively, but these sets showed
almost no GO term enrichments (see Table S4 in the supplemental
material).
Among the 371 deletions giving significant interactions in
comparisons 1 to 4 (Fig. 5A), there also are 63 genes annotated
with GO terms containing the term “mitochondrial.” However,
they did not score as an enriched GO term, given the high number
of such genes in the genome. As shown in Fig. 5H, most of these
genes were identified because they gave significant positive or neg-
ative interactions on Doxy, not on AbA, suggesting that Aur1 re-
pression by Doxy results in a kind of stress that is more easily
modulated by altered mitochondrial functions than the stress
caused by AbA.
Screens using AbA identify vacuolar acidification mutants.
Interestingly, mutants of set g (Fig. 5B), i.e., mutants found to give
negative interactions only in the two screens done with AbA and
not in those done with Doxy, did not show the GENIs mentioned
above (Table 1), but on the other hand, they were very strongly
enriched in several GO terms describing vacuolar acidification
(Table 1; see Tables S4 and S5 in the supplemental material). In-
deed, of the 18 genes required to constitute the vacuolar H-
ATPase (14 genes for ATPase subunits and 4 genes required for
their assembly), 15 were found in our screen as interacting nega-
tively with AbA (Fig. 5D; see Fig. S6A in the supplemental mate-
rial). As shown in Fig. S6B in the supplemental material, vacuolar
acidification (vma) mutants were found to be AbA hypersensitive
on serial dilution plates not only at high pH, at which vmamutants
are notoriously unable to grow (46), but also when placed in acidic
medium (pH 4.2), in which part of their vacuolar acidification
problem may be compensated by endocytosis (47). This suggests
that the real problem of cells under AbA stress may be their inabil-
ity to maintain an alkaline pH in the cytosol. Indeed, in vma2
cells grown at pH 5, the cytosolic pH was found to be 0.4 pH unit
lower than in the WT (48). Also, it was recently shown that vma
mutants endocytose Pma1, thereby reducing their ability to alka-
linize the cytosol (49).
Hypersensitivity of vmamutants to AbA is not explained by
inositol auxotrophy. Based on the literature, we wondered
whether vma mutants were exhibiting AbA hypersensitivity be-
cause of excessive inositol auxotrophy. For one, previous studies
by Susan Henry’s group demonstrated that SEY6210 WT cells in
the presence of 0.05 g/ml AbA or aur1ts cells are inositol auxo-
troph (Ino	) (29). Moreover, we realized that there was a 4- to
6-fold-higher-than-expected overlap between our “high-confi-
dence set” of negative interactions and Ino	 strains identified
through two recent high-throughput screens (48, 50). Strikingly,
one of these screens for Ino	 mutants had identified all 18 genes
coding for the building blocks or essential chaperones required for
the construction of the vacuolar proton ATPase (48). Thus, it
seemed important to understand whether the hypersensitivity to
AbA of our high-confidence set and, in particular, of the 15 vma
mutants came about because of an increased inositol requirement
under AbA stress. The following results strongly argued against
this. (i) All our screens were done in SC medium containing 430
M inositol, more than the 75 M used by Susan Henry’s group
(29). Confirming their results (29), we found that inositol enabled
WT cells to grow on AbA and Doxy (see Fig. S7A in the supple-
mental material) and that 10 M inositol was sufficient for max-
imal growth of WT on these drugs (see Fig. S7B in the supplemen-
tal material). However, inositol did not support growth of vma2
cells on AbA (Fig. S7A). (ii) Of the numerous significantly en-
TABLE 1 GO terms enriched in negative interactors identified by at least one AbA and one Doxy screen from Fig. 5Aa
GO term
Log10 exponent of P value for the enrichment of the indicated GO term
Interactions from this reportb Interactions from BIOGRIDc
tetAUR1.URA3 tetAUR1.YPC1
csg2 (278) orm2 (267) gas1 (332) pmr1(249)AbA (1) Doxy (2) AbA (3) Doxy (4)
Biological processes
Vesicle-mediated transport 	13 	4 	8 	6 	13 	9 	20 	22
Endosomal transport 	13 	4 	8 	7 	2 	4 	5 	5
Vacuolar transport 	10 	6 	6 	11 	5 	5 	5 	11
Retrograde transport, endosome-Golgi
apparatus
	5 — 	3 — — — 	2 —
Golgi vesicle transport 	5 — 	2 	2 	7 	5 	14 	14
Protein targeting to vacuole 	4 — — 	5 	6 	3 	4 —
Post-Golgi vesicle-mediated transport 	3 — 	3 	3 — — 	7 —
Late endosome-to-vacuole transport 	3 	3 	2 	4 — 	3 — 	5
Vacuolar acidification 	12 — 	19 — — — — —
Cellular components
Endosome 	12 	5 	13 	11 	2 	4 	5 	11
Endosome membrane 	8 	2 	9 	3 — 	4 — 	9
Golgi apparatus 	4 	2 	3 — 	15 	8 	18 	22
Vacuolar part 	2 — 	9 	3 — — — —
Vacuolar membrane 	2 — 	8 	2 — — — —
CORVET complex — — 	3 	6 — — — —
a Enrichments of GO terms relating to the “biological process” were obtained at http://yeastmine.yeastgenome.org/ with Holm-Bonferroni correction in place. —, P 0.05.
b Numbers in parentheses indicate the arrow number in Fig. 5A.
c Numbers in parentheses indicate the number of negative interactors.
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riched specific GO terms in the Ino	 mutant cells (48, 50), only
vacuolar acidification (GO0007035) is also present in our high
confidence set (Fig. 5B, fields a to k) (see Table S6 in the supple-
mental material), and the Ino	mutants identified in these studies
are not enriched in vacuolar protein sorting (vps) mutants or
other terms listed in Table 1.
AbA causes stronger inhibition of Aur1 in vma cells than in
WTcells.Although AbA is a very hydrophobic cyclic peptide lack-
ing nitrogen atoms that could be protonated, i.e., lacking lysoso-
motropic properties, we wondered if vacuolar H-ATPase mu-
tants showed reduced growth on AbA because they take up larger
amounts of AbA or degrade it less rapidly, so that the Golgi appa-
ratus-based Aur1 is exposed to higher concentrations of AbA lead-
ing to stronger Aur1 repression. We therefore labeled vma and
WT cells with [3H]inositol in graded concentrations of AbA in
order to test the efficacy of AbA to repress their sphingolipid bio-
synthesis (Fig. 6). To avoid second-site suppressors, we verified
that the vma mutants to be analyzed were unable to grow at high
pH in the presence of calcium (Fig. 6A) (46). When cells were
labeled with [3H]inositol, it appeared that AbA inhibited IPC and
MIPC biosynthesis more strongly in vma and vps6mutants than
in the WT, whereas the vps52mutant behaved like the WT (Fig.
6B). Interestingly, the vps6mutant belongs to the small subset of
vps mutants that exhibit a vacuolar acidification defect (51). La-
beling with [3H]inositol requires preculture of cells in inositol-
free medium, and this could compromise the viability of vmamu-
tants since they are inositol auxotrophic (48). Yet, in the
experiment of Fig. 6B, the total incorporation of [3H]inositol into
lipids in vmamutants was quite normal and was not influenced by
the presence of AbA (see Fig. S8A in the supplemental material).
To formally exclude any negative effect of inositol deprivation, we
chose to also label the cells with [14C]serine, this time in the pres-
ence of high concentrations of inositol (430 M). For this, a 5-h
labeling period was used. Here, the presence of AbA reduced total
incorporation of [14C]serine into lipids in a concentration-depen-
dent manner (see Fig. S8B in the supplemental material), and
incorporation correlated with the number of cell divisions occur-
ring during labeling (see Fig. S8C in the supplemental material).
As shown in Fig. 6C, [14C]serine labeling revealed (i) that 0.25
g/ml of AbA strongly reduced the IPC/MIPC synthesis in the
vma2 mutant but not in the WT and (ii) that, as judged from
lanes treated or not with NaOH, AbA caused a stronger accumu-
lation of ceramides in the vma2 mutant than in the WT. These
same observations were made in all vma mutants subjected to
[14C]serine labeling (Fig. 6D). Thus, both labeling with [3H]inosi-
tol and labeling with [14C]serine suggest that the AbA hypersen-
sitivity of vma mutants can be explained by a stronger inhibition
of Aur1 by AbA in vma mutants; the reason for this remains to be
elucidated. Other interesting observations in the experiment of
Fig. 6 are as follows. (i) It appears that [3H]inositol labeling, as we
had suspected, overestimates the efficiency of AbA to curtail the
synthesis of IPC and MIPCs in vma mutants, since 0.025 g/ml
AbA reduces the synthesis of IPCs and MIPCs in vma mutants by
about 50% as judged by [3H]inositol labeling but by only 10% as
FIG 6 AbA causes stronger inhibition of Aur1 in vma cells than in WT cells. (A) Tenfold dilutions of the indicated strains were plated on YPD or YPD with 50
mM HEPES (pH 7.5) and 50 mM CaCl2. (B) Cells growing for 14 h in inositol-free SC medium were labeled with [
3H]inositol for 2 h in the presence of various
concentrations of AbA. Lipid extracts were deacylated by mild base treatment and run on TLC. The amounts of mild-base-resistant sphingolipids made in the
absence of AbA were set as 100% for each strain, and the amounts of sphingolipids made in the presence of AbA were calculated as a percentage thereof.
(NaOH-resistant lipids accounted for 50.6%
 3.3% and 35.5%
 0.8% of total lipids in the WT and vma mutants, respectively.) (C) Autoradiograms of TLC
plates resolving lipid extracts from WT or vma2 cells having been labeled with [14C]serine with or without AbA and deacylated or not with NaOH. In all TLC
lanes, material from equivalent numbers of WT and mutant cells was separated. (D) Quantifications of the data of panel C (vma2) plus those from vma7 and
vma8mutants labeled in the same experiment. For each of the 12 labelings (4 strains labeled under three conditions [0, 0.025, and 0.25g/ml of AbA]), the total
amounts of label in the nondeacylated lipid extract were set as 100%, and the counts in IPCs plus MIPCs or in the stronger of the two bands in the ceramide region
present after NaOH treatment were expressed as a percentage thereof. Strain symbols are as in panel B.
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judged by [14C]serine labeling (Fig. 6B versus D). (ii) Here as well
as in many previous experiments, we observed a quantitative in-
crease of ceramides and the appearance of a new band with slightly
lower TLC mobility after mild base treatment which could be a
ceramide or a free fatty acid (Fig. 6C). It is possible that a signifi-
cant fraction of ceramides is esterified with the carboxyl group of
some polar substance(s), e.g., an amino acid(s), but we have not
been able to fully characterize the material comigrating with cer-
amides after mild base treatment.
Treatment of cells with aureobasidin A increases vacuolar
quinacrine accumulation. It seemed possible that the heightened
AbA sensitivity of IPC biosynthesis in vma mutants derives from
the fact that in AbA-treated cells the vacuolar acidification has to
compensate for cytosolic acidification or the imbalance of some
electrolytes. Quinacrine, a fluorescent compound that accumu-
lates in acidic compartments, was used to estimate the vacuolar
acidification under AbA (51, 52). For this, cells were preincubated
with AbA for 1 h, stained for 8 min at pH 7.6 with quinacrine,
washed, and viewed under the microscope. As shown in Fig. 7 and
more extensively in Fig. S9 in the supplemental material, treat-
ment of WT cells with AbA (0.25 g/ml) for 1 h led to a distinct
increase of vacuolar quinacrine accumulation, whereas treatment
with Doxy (10g/ml) for 7 h did not (not shown). As expected, no
quinacrine accumulation was seen in vma2 cells with or without
AbA treatment (Fig. 7; see Fig. S9 in the supplemental material).
The precise reason for the increased vacuolar acidification upon
AbA treatment is presently unknown.
Deletions decreasing ceramide levels enhance growth on
doxycycline. For growth-enhancing interactions (negative Z
scores), most of them were found with tetAUR1.YPC1 as a query
and by selecting on Doxy (Fig. 5D versus C, lower left quadrants;
see Fig. S10 in the supplemental material). The deletions that en-
hanced growth of tetAUR1.YPC1 on Doxy were enriched for
rather generic GO terms such as “regulation of RNA biosynthetic
processes,” but, interestingly, the term “sphingolipid biosynthetic
processes” (GO 0030148) also was enriched (P 0.009), with 7 of
the 14 genes in this GO term giving significant negative Z scores in
our screen (see Table S4 in the supplemental material). Interest-
ingly, gene deletions in all of the 7 hits (TSC3, LCB3, ELO2, ELO3,
SUR2, LAC1, or ISC1) (red in Fig. 1) ought to reduce ceramide
levels. This fits the notion elaborated based on Fig. 4C that YPC1
overexpression sustains growth of tetAUR1 cells on Doxy by re-
ducing ceramide levels. These data also confirm the reported hy-
perresistance of elo3 and sur2 strains under AUR1-repressing
conditions mentioned above. Moreover, 5 mutants reducing cer-
amide levels had already been found in preliminary screens, and
all of them showed improved growth in serial dilution growth
assays (red underlined in Fig. 1; see Fig. S11 and S12 in the sup-
plemental material).
Twenty-three deletions also enhanced growth of tetAUR1.YPC1
on AbA, and 18 among those also enhanced growth on Doxy (see
Fig. S10, fields a, b, d, and j, in the supplemental material), but
these 23 were not enriched for any GO term.
Comparisonwithpublishedhigh-throughput screens.While
these studies were in progress, a number of genetic interactions
with AUR1 damp clones gathered from high-throughput studies
were reported in BIOGRID (53, 54) (see Table S7 in the supple-
mental material). The 287 negative interactions in this set are
strongly enriched in the very same GO terms as our 134 high-
confidence set (fields a to k in Fig. 5B), but only 23 genes were
found to be common between BIOGRID and our high-confidence
set (Fig. 5G). However, all 3 subsets in Fig. 5G showed GENIs in
vacuolar and endosomal transport, indicating that neither our
screen nor the BIOGRID screen was exhaustive (see Table S7 in
the supplemental material).
Twenty-eight strains were common between our high-confi-
dence set and the hits identified in the diploid homozygous knock-
out collection through cocultivation of all nonessential deletion
strains in liquid cultures containing 0.02 g/ml AbA (55) (see
Table S8 in the supplemental material). This represents a 4-fold-
higher overlap than expected by chance. The 296 most sensitive
strains from reference 55 were enriched for “vacuolar acidifica-
tion” and similar GO terms (0.005  P  0.05) but for no other
terms in Table 1 (see Table S8 in the supplemental material). It
appears that vacuolar acidification also is required when cells are
stressed in liquid culture. No significant overlap of AbA-hyperre-
sistant hits in our study or the aur1-damp interactions in
BIOGRID with hyperresistant homozygous deletions from refer-
ence 55 was found.
AbA-treated cells have a morphologically normal Golgi ap-
paratus but enlarged lipid droplets. Based on the high sensitivity
to Aur1 repression in mutants with affected vesicular traffic be-
tween the Golgi apparatus and the vacuole, we tried to see whether
AbA or Doxy would cause morphological changes of the Golgi
apparatus in tetAUR1 cells expressing the Golgi protein Sec7-GFP
or Sed5-GFP. However, no convincing changes were observed
(not shown). We also monitored the distribution of GFP-labeled
plasma membrane proteins such as Can1, Fur4, and Gas1 under
AbA (0.05 or 0.25g/ml, 30°C, 1 to 7 h). In this case we also failed
to see accumulation of GFP in the ER or Golgi apparatus and only
occasionally found cells with increased vacuolar staining (data not
shown). Thus, at this level of sensitivity, it did not seem that AbA
caused a secretion block or destabilization of plasma membrane
proteins. We noted only that the volume of lipid droplets in-
creased upon AbA treatment, as judged from staining with the
hydrophobic BODIPY fluorescent dye (see Fig. S13A in the sup-
plemental material), suggesting that AbA may cause alterations of
the lipid metabolism beyond the sphingolipid metabolic path-
ways.
In support of this, mass spectrometric lipid profiling of cells
treated for 4 h with AbA indeed revealed major increases in TAGs
and sterol esters (SEs) along with strong reductions of phosphati-
FIG 7 AbA treatment increases vacuolar quinacrine accumulation. Exponen-
tially growing tetAUR1 and vma2 cells were harvested at an OD600 of 1.0 and
incubated with or without 0.25g/ml AbA at 30°C at pH 6.5 for 1 h. Cells were
then washed, stained with quinacrine, placed on ice, and viewed within 30 min,
during which period early and late viewings did not show any difference. All
pictures were taken under the same conditions and processed with ImageJ
(http://imagej.nih.gov/ij/) using the same window settings (see Materials and
Methods). This is a representative sample of the larger set of pictures shown in
Fig. S9 in the supplemental material. The transillumination and fluorescence
pictures were merged. Occasional brightly fluorescent cells increased with time
and were assumed to be dead cells.
Genetic Interactions of Yeast Aur1
December 2015 Volume 14 Number 12 ec.asm.org 1211Eukaryotic Cell
 o
n
 N
ovem
ber 5, 2017 by SYDDANSK UNIVERSITETSBIBLIO
TEK
http://ec.asm
.org/
D
ow
nloaded from
 
dylserine (PS) and phosphatidylethanolamine (PE) and a small
reduction in PI (Fig. 8A), in keeping with an increased volume of
lipid droplets in such cells. It also appeared that AbA treatment
increased the desaturation of fatty acids in TAGs (not shown). In
a pathological process leading to cell death, it is obviously not easy
to distinguish between events that cause cell death and events that
are just consequences of imminent cell death. However, the same
increase in neutral lipids and strong decrease in PS is also found in
lag1 lac1 ypc1 ydc1 SLC1-1 cells which are not undergoing
cell death but suffer from a constitutive lack of complex sphingo-
lipids, as appears under Aur1 repression (S.K. Mallela et al., un-
published data).
To see if the accumulation of sterol esters and TAGs helped
cells overcome the AbA-induced stress, we tested pah1 lpp1
dpp1 mutants retaining only 35% of the activity transforming
phosphatidic acid into diacylglycerol, the obligatory precursor for
TAG biosynthesis (56). As shown in Fig. 8B, this triple mutant
showed AbA hypersensitivity. Similarly, nem1 cells, lacking the
phosphatase required to activate Pah1, were found to be Doxy
hypersensitive in our screen. When viewed after BODIPY stain-
ing, pah1 lpp1 dpp1mutants had fewer lipid droplets than the
WT and made 3.5-fold less TAG than the corresponding WT, as
described before (56, 57) (see Fig. S13B and C in the supplemental
material). However, when treated with AbA they nevertheless ac-
cumulated dotty hydrophobic material (see Fig. S13B) and still
increased their TAG levels (see Fig. S13C), probably using the
remaining phosphatidate (PA) phosphatase App1. They also re-
duced PS and PE, like the WT (see Fig. S13C).
Surprisingly, blocking SE and TAG synthesis by simultane-
ously deleting/repressing ARE1, ARE2, LRO1, and DGA1 made
cells rather AbA resistant (Fig. 8C). It is possible that AbA-treated
cells are hypersensitive to PA, which accumulates in pah1 cells
but not in are1 are2 lro1 dga1 cells. PA is a central regulator
which sequesters the Opi1 transcriptional repressor and thereby
derepresses lipid biosynthesis (48).
DISCUSSION
Our data establish hydroxylated VLCFAs (C24:0;1 and C26:0;1) as an
indicator of futile cycling caused by simultaneous presence of al-
kaline ceramidases and acyl-CoA-dependent ceramide synthases,
but we cannot presently assert that they are a quantitative indica-
tor, since we have not excluded that these hydroxylated fatty acids
would again be utilized by Ypc1 or Ydc1 for reverse ceramide
synthesis, which may occur concomitantly with ceramide hydro-
lysis. We also have not excluded that they would be activated and
used by acyl-CoA-dependent ceramide synthases or be degraded
by peroxisomal -oxidation. Nevertheless, free C24:0;1 and C26:0;1
fatty acids seem to be much better indicators for such futile cycling
than LCBs, which can be elevated not only through increased
breakdown of ceramides (Fig. 2A) but also by increases in the
highly regulated de novo biosynthesis of LCBs or by downregula-
tion of the well-known LCB degradation pathway through Lcb4/
Lcb5 and Dpl1 (58).
As mentioned, a recent report showed that the reduction of
complex sphingolipids caused by AbA results in ER retention of
GPI-anchored proteins, ER stress, an unfolded-protein response,
ROS production, mitochondrial cytochrome c release, and a
metacaspase-mediated form of apoptosis that additionally is de-
pendent on the concomitant increase of cytosolic Ca2 concen-
trations (14). Our report confirms and adds new features to these
observations. As said above, we do not find evidence that ROS
would play a major role in AbA-induced apoptosis (Fig. 4D). Our
data, however, confirm that it is the reduction of IPCs rather than
accumulation of toxic ceramides that reduces cell viability under
AbA stress, but they also suggest that during the slow depletion of
Aur1 function under Doxy, it is rather the accumulation of cer-
amides which produces the major proapoptotic signal. We also
found that the deletion of the unfolded-protein response gene
IRE1 or HAC1 aggravates AbA and Doxy toxicity (Fig. 5D; see
Table S3 in the supplemental material), in keeping with the fact
that AbA induces an ER stress and arguing that the ensuing UPR
improves cell growth/survival. One mechanism would be that the
UPR relieves the reported accumulation of GPI proteins (14). On
the other hand, it is unlikely that a UPR-induced increase in LCB
biosynthesis, as observed in the conditional lcb1-100 mutant (32),
would help cells to overcome the AbA stress, since (i) such an
increase is not seen in WT cells, (ii) a reduction rather than an
increase of LCB and ceramide synthesis reduced AbA toxicity (Fig.
4C), and (iii) deletion of ORM1 or ORM2, repressors of LCB1/
LCB2, did not help cells under Aur1 repression (see Table S3A in
the supplemental material). Our data further confirm that pmr1
FIG8 AbA causes the accumulation of neutral lipids. (A) Exponentially grow-
ing WT and ypc1 ydc1 (yy) cells were extracted directly or further incu-
bated for 4 h with 0.25g of AbA. Lipid extracts were analyzed by MS. Results
are expressed as the percentage of lipids identified in positive (SE, TAG, and
PE) or negative (PS and PI) ion mode. Error bars for two technical replicates
are shown. Only lipids that change with AbA treatment are shown. Results are
from one of two experiments giving the same result. (B and C) Tenfold dilu-
tions of exponential-phase WT and pah1 lpp1 dpp1 cells (B) or tenfold
dilutions of exponential-phase cells carrying deletions in 3 of the 4 enzymes
making sterol esters (SEs) and TAGs (ARE1, ARE2, DGA1, and LRO1) and
having the promoter of the genomic copy of the fourth gene, either DGA1 or
LRO1, replaced by the GAL1 promoter (C) were plated onto YPD or YPGal
with the indicated concentrations of AbA and incubated for 2 (B) or 3 (C) days
at 30°C.
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cells are AbA hypersensitive (Table 2; see Table S3 and Fig. S11C
and E in the supplemental material), as reported before (14).
Pmr1 acts to reduce cytosolic calcium and prevents calcineurin
activation (59), and this probably explains why it helps to avoid
the calcium-dependent apoptosis induced by AbA (14).
We made the new observation that the protein transport to
vacuole, late endosome-to-vacuole transport, retrograde endo-
some-to-Golgi transport, Golgi vesicle transport, and similar pro-
cesses become critical when Aur1 activity is reduced (Table 1).
This was found in each one of the screens 1 to 4 (Fig. 5A), whether
Aur1 was repressed pharmacologically or transcriptionally and
whether or not YPC1 was overexpressed (see Table S4 in the sup-
plemental material), and this is confirmed by BIOGRID data.
Quite in the same line, elo3 (sur4) cells, having reduced levels of
sphingolipids, were found to be synthetically sick with vps21 and
vps3 cells (60), and our data seem to generalize this finding.
We have no clue to why such vacuolar transport becomes
essential when Aur1 is repressed, but it cannot possibly be the
aggravation of a defect in endocytosis or Golgi-to-vacuole
transport, since both of these processes are nonessential; intra-
Golgi transport, however, is part of the essential secretion pro-
cess.
Lack of IPCs leads to lack of MIPC and M(IP)2C and thereby
may affect numerous sphingolipid-dependent processes. We used
negative genetic interactions reported in BIOGRID to try to iden-
tify such downstream elements, failure of which could render the
biological processes indicated by Table 1 more essential. Interest-
ingly, deletion of CSG2 abolishes MIPC biosynthesis without in-
creasing ceramide levels (61), and csg2 shows negative interac-
tions with genes involved in the same processes as repressing
Aur1, although only 23 mutants were common between negative
csg2 interactors and our high-confidence set (subsets a to k in
Fig. 5B) (Table 1; see Table S9A in the supplemental material);
still, this represents 3 times more than expected by chance. Thus,
the comparison of GENIs of Aur1-repressed and csg2 cells sug-
gests that the essentiality of Golgi-vacuole transport in Aur1-re-
pressed cells may partially be mediated through the lack of MIPC.
GO terms connected to Golgi-vacuole traffic are also seen with
Doxy-treated cells, indicating that Doxy-treated cells also suffer
from a lack of MIPC, although they are greatly relieved by reduc-
tion of ceramide levels (Fig. 4C). Deletion of the M(IP)2C synthase
gene IPT1 (Fig. 1) did not cause negative interactions enriched in
any of the GO terms in Table 1 (see Table S9A in the supplemental
material). Lack of MIPC in turn has been shown (i) to cause
Slm1/2- and TORC2-dependent activation of the Ypk1 protein
kinase leading to inactivation of Orm proteins and activation of
LCB and ceramide biosynthesis (30, 62, 63), (ii) to inactivate the
aminophospholipid flippase at the plasma membrane (18), and
(iii) to activate the calcium-regulated phosphatase calcineurin
(61). Deletion of ORM2 mimics the functional Orm2 inactivation
through Ypk1-mediated Orm phosphorylation that occurs upon
AbA treatment (64, 65), and negative interactors of orm2 are
enriched in GO terms in Table 1 (see Table S9A and C in the
supplemental material). Thus, AbA treatment may render Golgi-
vacuole transport essential by activating Ypk1, but at the same
time this activation must have a very positive effect, since ypk1
mutants show a strong negative interaction with AbA (Fig. 5E; see
Fig. S11C and E in the supplemental material). This positive effect
may well be the Orm-mediated activation of LCB synthesis and
activation of ceramide synthase that may help to increase IPC
production under AbA-mediated Aur1-repression (18, 30, 63,
64). On the other hand, deletion of LEM3, an essential component
of the DNF1/DNF2/DNF3 aminophospholipid flippase, does not
generate the negative genetic interactions found after AbA treat-
ment (Table 1; see Table S9A in the supplemental material). Fi-
nally, cnb1 cells lacking calcineurin did not genetically interact
with Aur1 repression in our screen, nor is such an interaction
reported in BIOGRID. Still, genetic but not pharmacological re-
pression of calcineurin was found to enhance resistance to AbA
(14). We did not try to reproduce this, but it is possible that part of
the toxicity of AbA is mediated by calcium-mediated calcineurin
activation.
As shown in Table 1 and Table S9C in the supplemental mate-
rial, the GENIs of some mutants with mutations affecting the cell
wall integrity (gas1, gup1, and pmr1) are somewhat similar to
the ones of Aur1-repressed cells. Indeed, acute repression of
Aur1 by AbA activates the MAPK cell wall integrity (CWI)
pathway (29, 30) (Fig. 3C). Yet, GO terms concerning the fun-
gal cell wall biosynthesis and organization are not enriched in
our high-confidence set or the aur1 interactors reported in
BIOGRID. Also, deletions in 6 nonessential genes of the MAPK
pathway were present in our library (ROM1, ROM2, BCK1,
MKK1, MKK2, and SLT2), but essentially none of them showed
a negative interaction in our screens or with a hypomorphic
aur1 allele according to BIOGRID. This also agrees with the
finding that sorbitol could not improve viability of cells on AbA
(see Fig. S14 in the supplemental material), as had been men-
tioned in an earlier report (8). However, vma mutants showed
better AbA resistance on sorbitol (see Fig. S14). Thus, in WT
cells, AbA treatment readily triggers strong activation of the
CWI pathway, but this activation seems to be irrelevant in
TABLE 2 Summary of serial dilution growth tests done with deletion strains identified as sensitive or resistant to Aur1 repression in preliminary
screensa
Phenotype Identified genesb
AbA hypersensitive BST1, BUD14, ECM33, ERD1, ERG3, ERV14, FKS1, FYV6, GUP1, IML2, OPI9, LEO1, OSH3, PER1, PMR1, RPN4, RVS161,
SAC6, SHE2, SLG1, SNT1, SUR1, TEF4, YMR102C, YPK1, YSP2.
Doxy hypersensitive BTS1, COG5, COG6, DOA1, GOS1, GYP1, ITR1, MON2, PEP12, SCS7
Doxy resistant EGO1, ELO2, ELO3, FAT1, FOX2, GSG1, GUP1, ISC1, KEX2, LCB3, LEO1, MRPL36, SLG1, SUR2, YPT6
a In preliminary high-throughput SGA screens, the library containing 4,849 strains, each one deleted in a single nonessential gene, had been robotically crossed with either tetAUR1,
BY4742 (FBY5313), or BY4742 harboring pYPC1-URA3 (FBY5333) and plated on AbA or Doxy. Some hypersensitive or hyperresistant isolates of interest to us were picked and
further tested in the subsequent serial dilution growth assays shown in Fig. S11 and S12 in the supplemental material. Those deletion strains that reproduced the SGA result in the
growth test are listed in this table.
b Genes involved in sphingolipid metabolism are in bold, and those which, when deleted, cause at the same time AbA hypersensitivity and Doxy resistance are underlined.
Genetic Interactions of Yeast Aur1
December 2015 Volume 14 Number 12 ec.asm.org 1213Eukaryotic Cell
 o
n
 N
ovem
ber 5, 2017 by SYDDANSK UNIVERSITETSBIBLIO
TEK
http://ec.asm
.org/
D
ow
nloaded from
 
terms of cell survival, whereas in vma mutants the cell wall
defect may contribute to the negative effects of AbA.
The fact that vma mutants are hypersensitive to AbA may be
due to higher concentrations of AbA reaching Aur1 and/or a lack
of the physiological stimulation of the vacuolar H-ATPase in
reaction to AbA (Fig. 7; see Fig. S9 in the supplemental material).
Other effects may also contribute to the AbA hypersensitivity of
vmamutants, e.g., the accumulation of cytosolic calcium observed
in some vma mutants (59, 66), which can be explained by the fact
that the vacuolar pH gradient is necessary to drive Ca2 import
into vacuoles using the vacuolar Ca2/H antiporter Vcx1 (46).
The increase in cytosolic calcium may enhance the toxicity of AbA
(14) and itself cause the increased acidification of vacuoles in WT
cells upon AbA treatment (Fig. 7; see Fig. S9 in the supplemental
material).
In summary, our report shows that the mode of repression of
AUR1 can influence the spectrum of pathogenic events, that ve-
sicular traffic between Golgi apparatus, endosomes, and vacuole
becomes critical for cell survival in Aur1-repressed cells, and that
vacuolar acidification is an important defense mechanism when
Aur1 is acutely repressed by AbA.
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ADDENDUM IN PROOF
A similar paper showing the importance of the Golgi complex in cells with
reduced sphingolipid biosynthesis has been published since this paper was
typeset (F. Fröhlich, C. Petit, N. Kory, R. Christiano, H.-K. Hannibal-
Bach, M. Graham, X. Liu, C. S. Ejsing, R. V. Farese, Jr., T. C. Walther, eLife
4:e08712, 2015, http://dx.doi.org/10.7554/eLife.08712)
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